Int J Health Policy Manag. 2022;11(11): 2525-2532. doi: 10.34172/ijhpm.2021.180

PMID: 35065545 PMCID: PMC9818092

Original Article

Developing a How-to-Guide for Health Technology Reassessment: "The HTR Playbook"

Lesley J.J. Soril ^1,2 , Adam G. Elshaug ^3,4, Rosmin Esmail ^1,5, Kalipso Chalkidou ^6,7, Mohamed Gad ^6,7, Fiona M. Clement ^1,2 *

Cited by CrossRef:

1- Bharmal M, Katsoulis I, Chang J, Graham A, Stavropoulou A, Jhingran P, Pashos C. Real-world evidence in the reassessment of oncology therapies: payer perceptions from five countries. Future Oncology. 2024;20(21):1467 [Crossref]

2- Becchetti A, Martini A, Scroccaro G, Joppi R. History of trastuzumab: a case study in health technology reassessment and natural disinvestment in Veneto Region. Front Pharmacol. 2024;15 [Crossref]

Submit Your Paper Archive